| |
| |
|
| Insider
Information: |
Stark David Matthew |
| Relationship: |
Exec. VP Chief Legal O... |
| City: |
Petach Tikva |
| State: |
L3 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
2,974 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$41,577 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,974 |
|
|
| Total
Value |
$41,577 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Teva Pharmaceutical Industries L... |
TEVA |
Exec. VP Chief Legal O... |
2023-03-07 |
2,974 |
2018-03-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP Chief Legal Officer |
• – – |
2023-03-07 |
4 |
AS |
$9.43 |
$466,445 |
D/D |
(49,475) |
2,974 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP Chief Legal Officer |
• – – |
2023-03-06 |
4 |
AS |
$9.93 |
$163,770 |
D/D |
(16,491) |
52,449 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP Chief Legal Officer |
• – – |
2023-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,199 |
68,940 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP Chief Legal Officer |
• – – |
2023-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
45,767 |
48,741 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP Chief Legal Officer |
• – – |
2023-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
63,383 |
47,927 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP Chief Legal Officer |
• – – |
2023-02-28 |
4 |
AS |
$9.89 |
$626,642 |
D/D |
(63,383) |
2,974 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP Chief Legal Officer |
• – – |
2022-07-28 |
4 |
AS |
$9.04 |
$525,590 |
D/D |
(58,163) |
2,974 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP Chief Legal Officer |
• – – |
2022-03-07 |
4 |
AS |
$7.37 |
$66,720 |
D/D |
(9,057) |
61,137 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP Chief Legal Officer |
• – – |
2022-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,199 |
70,194 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP Chief Legal Officer |
• – – |
2022-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
51,869 |
56,241 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP Chief Legal Officer |
• – – |
2022-03-04 |
4 |
AS |
$7.48 |
$173,998 |
D/D |
(23,254) |
49,995 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP Chief Legal Officer |
• – – |
2022-02-28 |
4 |
AS |
$8.14 |
$52,533 |
D/D |
(6,452) |
21,380 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP Chief Legal Officer |
• – – |
2022-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,430 |
27,832 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP Chief Legal Officer |
• – – |
2022-02-09 |
4 |
AS |
$9.06 |
$55,358 |
D/D |
(6,110) |
9,402 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP Chief Legal Officer |
• – – |
2022-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,538 |
15,512 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP Chief Legal Officer |
• – – |
2021-05-11 |
4 |
AS |
$10.22 |
$387,125 |
D/D |
(37,884) |
2,974 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP Chief Legal Officer |
• – – |
2021-05-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
37,884 |
40,858 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP Chief Legal Officer |
• – – |
2021-03-04 |
4 |
AS |
$10.57 |
$147,186 |
D/D |
(13,930) |
2,974 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP Chief Legal Officer |
• – – |
2021-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,930 |
16,904 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP Chief Legal Officer |
• – – |
2021-03-01 |
4 |
AS |
$10.83 |
$199,612 |
D/D |
(18,430) |
2,974 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP Chief Legal Officer |
• – – |
2021-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,430 |
21,404 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP Chief Legal Officer |
• – – |
2021-02-16 |
4 |
AS |
$11.12 |
$43,669 |
D/D |
(3,926) |
2,974 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP Chief Legal Officer |
• – – |
2021-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,926 |
6,900 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP Chief Legal Officer |
• – – |
2021-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,538 |
15,512 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Exec. VP Chief Legal Officer |
• – – |
2021-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
52,774 |
68,286 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
